Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
The Boston Children's Hospital Neonatal and Congenital Anomaly Neurosurgery Program was created to diagnose and treat neurologic anomalies as early as possible so that these patients have the greatest chance of experiencing optimal development and leading healthy full, healthy lives.
The Neonatal and Congenital Anomaly Neurosurgery Program at Boston Children’s Hospital evaluates, diagnoses and treats newborns with neurologic congenital anomalies. A congenital anomaly is sometimes identified during the mother’s pregnancy or soon after the birth of the baby.
Some neurologic congenital anomalies include:
Our program includes an experienced multidisciplinary team of clinicians, all with specialized training in the care of children with neurologic congenital anomalies. Our team members represent multiple departments, programs and services across Boston Children's, including:
About our director: Benjamin Warf, MD
Dr. Warf received his medical degree from Harvard University. He began his career in pediatric neurosurgery at Boston Children's Hospital in 1991 as the first Pediatric Fellow in Neurological Surgery. From Boston Children’s, he took a position at University of Kentucky where he became Chief of Pediatric Neurosurgery.
In 2000, Dr. Warf and his family moved to Uganda to help found a hospital for pediatric neurosurgery with CURE International, a non-profit Christian medical mission organization. While at CURE, he served as Medical Director and established the only pediatric neurosurgery hospital in Sub-Saharan Africa.
Dr. Warf was the first to identify neonatal infection as the chief cause of pediatric hydrocephalus in a developing country, and remains involved in working to uncover its pathogenesis in order to ultimately construct prevention strategies. He developed a novel surgical technique for treating hydrocephalus in infants, combining endoscopic third ventriculostomy with bilateral choroid plexus cauterization (ETV/CPC).
Since returning to the United States, Dr. Warf has investigated the role of ETV/CPC in North American infants, and also continues to work in international neurosurgery development. From 2006 to 2009, Dr. Warf was neurosurgeon at Dupont Hospital for Children in Wilmington, Delaware. He rejoined the team at Boston Children’s in 2009.
Read more about Dr. Warf:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”